Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 467-472

  Feugeas, O ^a   Guriec, N ^a   Babin Boilletot, A ^a   Marcellin, L ^a   Simon, P ^a   Babin, S ^a   Thyss, A ^a   Hofman, P ^a   Terrier, P ^a   Kalifa, C ^a   Brunat Mentigny, M ^a   Patricot, L M ^a   Oberling, F ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DNA POLYMORPHISM; EARLY DIAGNOSIS; GENE ACTIVATION; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTICENTER STUDY; OSTEOSARCOMA; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR SUPPRESSOR GENE;

EID: 9044238439     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.467     Document Type: Article

References (30)

1. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221-1230, 1982
2. Wadayama BI, Toguchida J, Shimizu T, et al: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54:3042-3048, 1994
3. Friend SH, Bernards R, Rogeli S, et al: A human DNA segment with properties of the gene that predispose to retinoblastoma and osteosarcoma. Nature 323:643-646, 1986
4. Lee WH, Bookstein R, Hong F, et al: Human retinoblastoma susceptibility gene: Cloning, identification and sequence. Science 235:1394-1399, 1987
5. Weinberg RA: Tumor suppressor genes. Science 254:1138-1146, 1991
6. Benedict WF, Xu HJ, Hu SX, et al: Role of the retinoblastoma gene in initiation and progression of human cancer. J Clin Invest 85:988-993, 1990
7. Stratton MR, Moss S, Warren W, et al: Mutation of the p53 gene in human soft tissue sarcomas: Association with abnormalities of the RB1 gene. Oncogene 5:1297-1301, 1990
8. Harbour JW, Lai SL, Whang-Peng J, et al: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353-357, 1988
9. Horowitz JM, Park SH, Bogenmann E. et al: Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 87:2775-2779, 1990
10. Ahuja HG, Jat PS, Foti A, et al: Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 78:3259-3268, 1991
11. Hansen MF, Koufos A, Gallie BL, et al: Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82:6216-6220, 1985
12. Yamaguchi T, Toguchida J, Yamamuro T: Allelotype analysis in osteosarcomas: Frequent allele loss on 3q, 13q, 17p and 18q. Cancer Res 52:5419-2423, 1992
13. Scholz RB, Kabisch H, Weber B, et al: Studies of the RB1 gene and p53 gene in human osteosarcomas. Pediatr Hematol Oncol 9:125-137, 1992
14. Kalifa C, Brunat-Mentigny M, Pacquement H, et al: treatment of osteosarcoma with an intensive chemotherapy regimen (OS87 protocol). Proc Am Soc Clin Oncol, 1993 (abstr 1464)
15. Huvos AG, Rosen G, Marcove RC: Primary osteogenic sarcoma. Pathologic aspects in twenty patients after treatment with chemotherapy, in bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101:14-18, 1977
16. Wright DK, Manos MM: Sample preparation from paraffin-embedded tissues, in Innis MA, Gelfand DH, Sninsky JJ, et al (eds): PCR Protocols: A Guide to Methods and Applications. San Diego, CA, Academic, 1990, pp 153-158
17. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215, 1988
18. Yandell DW, Dryja TP: Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet 45:547-555, 1989
19. Huang Y, Boynton RF, Blount PL: Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Canc Res 52:6525-6530, 1992
20. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
21. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observations of each patients. Br J Cancer 35:1-39, 1977
22. Vogelstein B, Fearon ER, Kern SE, et al: Allelotype of colorectal carcinoma. Science 244:207-210, 1989
23. Sopta M, Gallie BL, Gill RM, et al: The retinoblastoma protein and the cell cycle. Semin Cancer Biol 3:107-112, 1992
24. Müller H, Lukas J, Schneider A, et al: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91:2945-2949, 1994
25. Cavenee WK, Dryja TP, Philips RA, et al: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784, 1983
26. Feinberg AP: Genomic imprinting and gene activation in cancer. Nat Genet 4:110-113, 1992
27. Toguchida J, Ishizaki K, Sasaki MS, et al: Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 338:156-158, 1989
28. Ferguson-Smith AC, Reik W, Surani MA: Genomic imprinting and cancer. Cancer Surv 9:487-503, 1990
29. Huang HJ, Yee JK, Shew JY, et al: Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563-1566, 1988
30. Meyers PA, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992